Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 2Unknown 1Completed 1

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Gastrointestinal 4Gynecologic 2Genitourinary 2Breast 2

Conditions

Carcinoma, Hepatocellular 3Pancreatic Neoplasms 1

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1114Gemcitabine 1057Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 676Radiotherapy 560Cetuximab 482pembrolizumab 435Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 328Docetaxel 290Sorafenib 288S 1 (combination) 279Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 257lenvatinib 222sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Hydroxymethylglutaryl-CoA Reductase Inhibitors × Gastrointestinal × Clear all
NCT04245644 2024-03-12

CAOS

IRCCS San Raffaele

Unknown
800 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT03219372 2021-01-22

Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence

Cedars-Sinai Medical Center

Phase 2 Terminated
1 enrolled 5 charts
Gastrointestinal

Carcinoma, Hepatocellular

NCT03490461 2018-04-06

Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver Transplantation

Yonsei University

Completed
350 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02819869 2017-04-19

The Combination Effect of Statin Plus Metformin on Relapse-free

Taipei Medical University WanFang Hospital

Phase 2 Terminated
3 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡